SwedenBIO Blogg

2009-02-11 by Karin Aase

The Good and the Bad - Ethics in the Pharma industry

I have seen movies and read articles where the Pharma industry (and according to “guilt by association” also the biotech industry) is described as any thing else but ethical with the sole interest of making as much money as fast as possible, and little regard is taken to the well being of animals and humans or to the environment.

Academic researchers on the other hand, are more often than not described as hard working men (and sometimes women) with a mission. They have high moral standards and are not driven by Mammon, but by a will to do Good.

Is this true? Are there two different breeds of life science researchers, one profit-hungry and one with a calling? Of course not!

As any other company out there, also the Pharma industry has to survive in the global world of economics. It is somehow ok for Volvo to make money, but not for AstraZeneca. But of course you say; “Volvo makes safe cars, whereas AstraZeneca profit on the weak and needy”.

Stop a moment and let’s think about this for a while. Does the man in the street really think it is more ok to make environmental hazardous cars, but not to make medicines that save peoples life? Because that is exactly what the Pharma and biotech industry does – invent pills and gadgets to save peoples life!

Having said this, I don’t state that people working in the industry are all Good, but neither is people in academia – there are black sheep in all families, period.

Contrary to the academia though, the life science industry has, in an effort to minimize the risk of any wrong doing and setting the standards for good practice, finalized a project called “From GMP to GBP: fostering Good Bioethical Practices among European Biotechnology Industry”. Within this project, representatives from the industry have discussed different issues with lawyers and ethics experts. The end product will be a bioethical guideline for the industry and recommendations to the European legislators.

In addition, the life science industry has via their industry organisations, updated their Core Ethical Values. This document is an important statement from the industry, where its principles are laid down. I am still waiting for such a statement from the academic world, as ethics should not solely be a matter for the “profit-hungry” industry.


Comments:

  1. I fully agree that the common picture of our industry is distorted and unjust, considering all the hardworking and morally driven people working here. However, we cannot just put the blame for our poor reputation on media and moviemakers. We must look at ourselves through the specs of our viewers. We have not been very transparent and we have not been good at explaining how our industry works. Although, many of the companies in "big pharma" have improved much, there is still a lot of work to be done in order to gain trust and a fair appreciation from our external stakeholders. Even smaller companies need to improve in their external communication. Investors, media, patients and "activists" all seek information about ongoing research, development project etc on readily accessible sources such as the internet. The small companies also need to openly address issues and dilemmas they are facing and demonstrate, for instance, how clinical benefits outweigh risks or side effects or how treatment costs can reduce sociectal costs. We all must contribute to changing the image of our industry. Better communication and increased transparency is the way to do this. Ethical guidelines, codes of conduct etc are a good starting point.

Post a comment
Enter number: